erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before. .
helen, from marion, ill., had three children from a previous marriage.
. may 15, 2018
.
senator: i�m looking through the trillion-dollar federal budget. i�m looking for the money allocated to fix this horrible situation. where are those funds? .